Relay Therapeutics, Inc.
Recent Filings
All 487 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| SCHEDULE 13G | — | Mar 19, 2026 |
| 8-K | 8-K | Mar 16, 2026 |
| 4 | 4 | Mar 11, 2026 |
| 8-K | 8-K | Mar 11, 2026 |
| 144 | — | Mar 9, 2026 |
| S-8 | S-8 | Feb 26, 2026 |
| 10-K | 10-K | Feb 26, 2026 |
| 8-K | 8-K | Feb 26, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Patel Sanjiv | President and CEO | Sale | 62,073 @ $7.00 | 703,215 | Nov 3, 2025 |
| Rahmer Peter | See remarks | Sale | 19,135 @ $7.29 | 358,863 | Oct 29, 2025 |
| Catinazzo Thomas | Chief Financial Officer | Sale | 21,664 @ $7.29 | 313,631 | Oct 28, 2025 |
| Bergstrom Donald A | President, R&D | Sale | 30,897 @ $7.29 | 521,823 | Oct 28, 2025 |
| Rahmer Peter | See remarks | Sale | 1,359 @ $3.74 | 393,722 | Jul 29, 2025 |
| Bergstrom Donald A | President, R&D | Sale | 4,069 @ $3.74 | 579,421 | Jul 29, 2025 |
| Adams Brian | Chief Legal Officer | Sale | 1,637 @ $3.74 | 389,748 | Jul 29, 2025 |
| Catinazzo Thomas | Chief Financial Officer | Sale | 18,380 @ $3.68 | 335,295 | Jul 28, 2025 |
| Patel Sanjiv | President and CEO | Sale | 42,740 @ $3.57 | 783,927 | Jul 9, 2025 |
| Rahmer Peter | See remarks | Award / Grant | 5,000 @ $2.94 | 395,081 | Jun 30, 2025 |